Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.

Suh JH, Stea B, Nabid A, Kresl JJ, Fortin A, Mercier JP, Senzer N, Chang EL, Boyd AP, Cagnoni PJ, Shaw E.

J Clin Oncol. 2006 Jan 1;24(1):106-14. Epub 2005 Nov 28.

PMID:
16314619
3.

Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.

Stea B, Suh JH, Boyd AP, Cagnoni PJ, Shaw E; REACH Study Group.

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1023-30. Epub 2006 Jan 30.

PMID:
16446056
4.

Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.

Choy H, Nabid A, Stea B, Scott C, Roa W, Kleinberg L, Ayoub J, Smith C, Souhami L, Hamburg S, Spanos W, Kreisman H, Boyd AP, Cagnoni PJ, Curran WJ.

J Clin Oncol. 2005 Sep 1;23(25):5918-28.

PMID:
16135463
5.

Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.

Charpentier MM.

Ann Pharmacother. 2005 Dec;39(12):2038-45. Epub 2005 Oct 25. Review.

PMID:
16249270
6.

Role of efaproxiral in metastatic brain tumors.

Engel RH, Kaklamani VG.

Expert Rev Anticancer Ther. 2006 Apr;6(4):477-85. Review.

PMID:
16613536
7.

Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.

[No authors listed]

Drugs R D. 2005;6(3):178-85. Review.

PMID:
15869322
8.

Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.

Hu C, Chang EL, Hassenbusch SJ 3rd, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z.

Cancer. 2006 May 1;106(9):1998-2004.

9.

Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.

Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1069-76. doi: 10.1016/j.ijrobp.2008.05.068. Epub 2008 Oct 30.

PMID:
18977094
10.

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF.

J Clin Oncol. 2003 Jul 1;21(13):2529-36.

PMID:
12829672
11.

A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.

Guerrieri M, Wong K, Ryan G, Millward M, Quong G, Ball DL.

Lung Cancer. 2004 Oct;46(1):107-11.

PMID:
15364138
12.

Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases.

Stea B, Shaw E, Pintér T, Hackman J, Craig M, May J, Steffen RP, Suh JH.

Br J Cancer. 2006 Jun 19;94(12):1777-84.

13.
14.
15.

RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.

Shaw E, Scott C, Suh J, Kadish S, Stea B, Hackman J, Pearlman A, Murray K, Gaspar L, Mehta M, Curran W, Gerber M.

J Clin Oncol. 2003 Jun 15;21(12):2364-71.

PMID:
12805339
16.

Brain metastases in breast cancer: prognostic factors and management.

Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK.

Breast Cancer Res Treat. 2008 Oct;111(3):523-30. Epub 2007 Nov 8.

PMID:
17990100
17.

Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?

Carolan H, Sun AY, Bezjak A, Yi QL, Payne D, Kane G, Waldron J, Leighl N, Feld R, Burkes R, Keshavjee S, Shepherd F.

Lung Cancer. 2005 Jul;49(1):109-15. Epub 2005 Feb 2.

PMID:
15949596
18.

[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].

Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.

Ai Zheng. 2006 Nov;25(11):1419-22. Chinese.

PMID:
17094913
19.

Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.

Pöttgen C, Eberhardt W, Grannass A, Korfee S, Stüben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V, Budach V, Wilhelm H, Wanke I, Hirche H, Wilke HJ, Stuschke M.

J Clin Oncol. 2007 Nov 1;25(31):4987-92.

PMID:
17971598
20.

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ Jr, Robins HI, Movsas B, Brachman DG, Henderson RH, Mehta MP.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):79-86. doi: 10.1016/j.ijrobp.2007.09.016. Epub 2007 Dec 31.

PMID:
18164847

Supplemental Content

Support Center